Biological Psychiatry

94.9k papers and 3.6M indexed citations
i
.

About

94.9k papers covering Biological Psychiatry have received a total of 3.6M indexed citations since 1950. Papers on subfields are most often about the specific topic of Tryptophan and brain disorders, Stress Responses and Cortisol and Neuroinflammation and Neurodegeneration Mechanisms and also cover the fields of Behavioral Neuroscience, Molecular Biology and Psychiatry and Mental health. Papers citing papers on subfields are usually about Molecular Biology, Behavioral Neuroscience and Physiology. Some of the most active scholars covering Biological Psychiatry are Bruce S. McEwen, Michaël Maes, Andrew H. Miller, Robert Dantzer, Timothy G. Dinan, John F. Cryan, Charles B. Nemeroff, Lewis A. Opler, Stanley R. Kay and Abraham Fiszbein.

In The Last Decade

Biological Psychiatry

29.1k papers receiving 460.0k citations

Fields of papers citing papers about Biological Psychiatry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers covering Biological Psychiatry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers covering Biological Psychiatry.

Countries where authors publish papers about Biological Psychiatry

Since Specialization
Citations

This map shows the geographic impact of research in Biological Psychiatry. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers about Biological Psychiatry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biological Psychiatry more than expected).

The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia 1987 2026 2000 2013 16.8k
  1. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia (1987)
  2. Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies (2013)
  3. From inflammation to sickness and depression: when the immune system subjugates the brain (2007)
  4. The ‘Trier Social Stress Test’ – A Tool for Investigating Psychobiological Stress Responses in a Laboratory Setting (1993)
  5. The amyloid hypothesis of Alzheimer's disease at 25 years (2016)
  6. Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report (2006)
  7. Inflamm‐aging: An Evolutionary Perspective on Immunosenescence (2000)
  8. Alzheimer's Disease (2010)
  9. A Meta-Analysis of Cytokines in Major Depression (2009)
  10. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation (2013)
  11. Cross-talk between <i>Akkermansia muciniphila</i> and intestinal epithelium controls diet-induced obesity (2013)
  12. The Neuroendocrinology of Stress: A Never Ending Story (2008)
  13. Spectroscopic Determination of Tryptophan and Tyrosine in Proteins<sup>*</sup> (1967)
  14. Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain (2007)
  15. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour (2012)
  16. Clozapine for the Treatment-Resistant Schizophrenic (1988)
  17. Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression (2009)
  18. Behavioral despair in mice: a primary screening test for antidepressants. (1977)
  19. Mechanisms Underlying Inflammation in Neurodegeneration (2010)
  20. Antidepressant effects of ketamine in depressed patients (2000)
  21. Ingestion of <i>Lactobacillus</i> strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve (2011)
  22. Stress and the Individual (1993)
  23. Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans (1994)
  24. A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression (2006)
  25. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis (1992)
  26. Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis (2015)
  27. The role of inflammation in depression: from evolutionary imperative to modern treatment target (2015)
  28. Network Analysis: An Integrative Approach to the Structure of Psychopathology (2013)
  29. Normal gut microbiota modulates brain development and behavior (2011)
  30. Maternal Care, Hippocampal Glucocorticoid Receptors, and Hypothalamic-Pituitary-Adrenal Responses to Stress (1997)
  31. Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders (2013)
  32. Gut microbiota, metabolites and host immunity (2016)
  33. Cytokines sing the blues: inflammation and the pathogenesis of depression (2005)
  34. mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists (2010)
  35. Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis (2009)
  36. The molecular neurobiology of depression (2008)
  37. Complement and microglia mediate early synapse loss in Alzheimer mouse models (2016)
  38. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018)
  39. Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry. (2004)
  40. Subgenual prefrontal cortex abnormalities in mood disorders (1997)
  41. Stress signalling pathways that impair prefrontal cortex structure and function (2009)
  42. Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism (1998)
  43. The role of short-chain fatty acids in microbiota–gut–brain communication (2019)
  44. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis (2018)
  45. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease (2018)
  46. Drug Abuse: Hedonic Homeostatic Dysregulation (1997)
  47. Ido expression by dendritic cells: tolerance and tryptophan catabolism (2004)
  48. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase (2003)
  49. Tryptophan Catabolites from Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity via Interleukin-22 (2013)
  50. Cortical inhibitory neurons and schizophrenia (2005)
  51. A Specific Laboratory Test for the Diagnosis of Melancholia (1981)
  52. A network theory of mental disorders (2017)
  53. The ecology of the microbiome: Networks, competition, and stability (2015)
  54. The Sympathetic Nerve—An Integrative Interface between Two Supersystems: The Brain and the Immune System (2000)
  55. A Molecular and Cellular Theory of Depression (1997)
  56. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011)
  57. Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys (2009)
  58. Altered fecal microbiota composition in patients with major depressive disorder (2015)
  59. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant (1987)
  60. Immune attack: the role of inflammation in Alzheimer disease (2015)
  61. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition (2014)
  62. Inflammation as a central mechanism in Alzheimer's disease (2018)
  63. Schizophrenia risk from complex variation of complement component 4 (2016)
  64. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease (2015)
  65. Hippocampal atrophy in recurrent major depression. (1996)
  66. Dopamine in schizophrenia: a review and reconceptualization (1991)
  67. Microbiota in health and diseases (2022)
  68. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses (2011)
  69. Major Depressive Disorder (2008)
  70. Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model (2007)
  71. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation (1997)
  72. Stress-induced immune dysfunction: implications for health (2005)
  73. Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival (2007)
  74. Gut microbiome alterations in Alzheimer’s disease (2017)
  75. Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex (1997)
  76. From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014)
  77. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism (2016)
  78. Green tea composition, consumption, and polyphenol chemistry (1992)
  79. The HPA axis in major depression: classical theories and new developments (2008)
  80. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor (2011)

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore fields with similar magnitude of impact

Breakdown of academic impact, for papers covering Behavioral Neuroscience Breakdown of academic impact, for papers covering Immunology and Allergy Breakdown of academic impact, for papers covering Sensory Systems Breakdown of academic impact, for papers covering Developmental Neuroscience Breakdown of academic impact, for papers covering Molecular Medicine Breakdown of academic impact, for papers covering Endocrine and Autonomic Systems Breakdown of academic impact, for papers covering Applied Psychology
Rankless by CCL
2026